:format(jpeg)/cloudfront-us-east-1.images.arcpublishing.com/gfrmedia/KJZ77L5KMNF2LGILWOTC6QNQ2Y.jpg)
The 67th World Health Assembly of the World Health Organization (WHO) recognized in 2014 that psoriasis is a non-communicable, chronic, painful disease for which there is still no cure.
10 years after this historic resolution, the Puerto Rican Association to Help Psoriasis Patients (APAPP) invited psoriasis patients to a educational activity and annual assembly that will take place on Saturday, June 1 at 8:30 am to 1:00 pm at John Dewey University, located in the Lomas Industrial Park, in Juana Diaz. The activity is free of cost.
“This resolution represents an endorsement by the WHO of the demands of psoriasis patient associations around the world to improve access to treatments and medical care that patients need and deserve, as well as to work to eliminate the exclusion that many patients face,” he indicated through written statements Leticia Lopez, executive director of APAPP.
The resolution also calls for the development of campaigns to promote awareness regarding the disease and fight against the stigmatization suffered by people, the development of research, among other issues. “In Puerto Rico we urge that the Vital plan include psoriatic disease as part of the special conditions,” Lopez added.
According to reports, during the activity Participants will benefit from a series of educational talks and workshops led by different health specialists that will address different aspects of psoriasis disease such as: “Conference on psoriatic disease”, by dermatologist, Dr. Jaime Villa; “Psoriasis and the impact on mental health”, by psychologist Lorna Pena; and “Chiropractic and other treatments in the search for relief”, by Dr. Oscar Otero, among others.
Likewise, within the educational agenda there will be spaces for fraternization and dialogue between patients so that they can share their experiences with the disease. The event will have an area of educational tables and health clinics. The entire program will be broadcast live on the social network APAP Psoriasis on Facebook and @Behealthpr.
The WHO resolution also highlights that people with psoriasis may suffer from other comorbidities, such as: cardiovascular diseases, diabetes, obesity, Crohn’s disease, myocardial infarction, ulcerative colitis, metabolic syndrome, stroke, among others.
“For the past 14 years we have organized different educational events so that patients with these diseases know their pathology better, providing them with resources that allow them to empower themselves in their disease. “When the patient knows their condition is when they can manage its impact on a day-to-day basis,” he highlighted. Lopez.
